Replies to post #171640 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

The 2nd cohort won't start until the safety committee oks it after reviewing results from first cohort.

https://clinicaltrials.gov/ct2/show/NCT03042702?term=cellceutix&rank=2&flds=abcefgnps&submit_fld_opt=

Follow-up for 3 weeks after Kevetrin treatment ends Cohorts 1 and 2 will be conducted in a sequential fashion, with safety data from cohort 1 evaluated by an independent Data Monitoring Committee (DMC). The DMC will make appropriate recommendations based on the available safety data as regards the intent of progressing to the higher dose cohort 2.

In Reply to 'runninggirl2016'
So the 250mg and 350mg patients can be dosed together.
We don't wait for the 250mg patients to complete before the 350mg are dosed, like UP.

Hmmmm results after 3 weeks.

If I'm 1 of those BP with a CDA and see K is working, I make a deal asap.

A K deal may be our 1st deal.